Home › Compare › SEBYY vs ABBV
SEBYY yields 5.85% · ABBV yields 3.06%● Live data
📍 SEBYY pulled ahead of the other in Year 1
Combined, SEBYY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SEBYY + ABBV for your $10,000?
SEB SA designs, manufactures, and markets small household appliances worldwide. It provides electrical cooking, food preparation, and beverage preparation products, including electrical cooking products comprising deep fryers, rice cookers, electric pressure cookers, informal meal appliances, waffle makers, grills, toasters, multicookers, coffee makers, espresso machines, electric kettles, home beer-taps, soy-milk makers, blenders, cooking food processors, kitchen machines, mixers, beaters, etc. The company also offers linen, home, and personal care products, such as irons and steam generators, garment steamers, canister vacuum cleaners with or without dust bag, steam and upright vacuum cleaners, vacuum weepers, versatile vacuums, robots, fans, heaters, air treatment appliances, hair care appliances, depilators, electrical beard trimmers, hair clippers, and bathroom scales. In addition, it provides cookware products, such as frying pans, saucepans pots, pressure cookers, bakeware, kitchen utensils, food storage containers, vacuum flasks, thermo mugs, cutlery, and other products. Further, the company offers hotel equipment, crepe and waffle makers, planchas, and grills for professionals. It provides its products under various brands that primarily include Calor, Rowenta, Moulinex, Seb, Tefal, Krups, Lagostina, WMF, Schaerer, Wilbur Curtis, Hepp, Krampouz, Arno, Supor, Imusa, All-Clad, and Silit. The company was founded in 1857 and is headquartered in Écully, France.
Full SEBYY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.